Zaltrap

Zaltrap (aflibercept) is a prescription medication used in combination with other treatments for certain types of cancer. This overview covers its general uses and safety considerations for informational purposes.

Zaltrap, known generically as aflibercept, is used alongside chemotherapy to treat metastatic colorectal cancer in adults. It belongs to a class of medications that work by blocking blood vessel growth in tumors. Patients often ask, what is Zaltrap used for, and it is specifically indicated for advanced cancer cases when combined with standard chemotherapy regimens.

Aflibercept works by interfering with the formation of new blood vessels that tumors need to grow and spread. This action may help slow the progression of cancer. Common effects may include changes in blood pressure or fatigue, which are monitored during treatment. Individual responses can vary widely.

Zaltrap is administered intravenously under medical supervision due to its potent effects. Patients should inform their healthcare provider about all medications and conditions before starting treatment. Regular monitoring of blood pressure and blood work is typically required during therapy.

Aflibercept may interact with other medications that affect blood pressure or blood clotting. Combining it with certain chemotherapy drugs or other biologics could alter effectiveness or increase side effects. Always disclose all current medications to your healthcare provider before treatment begins.